Cargando…
A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers
Autor principal: | Stoller, Kenneth B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347582/ http://dx.doi.org/10.1186/1940-0640-10-S1-A63 |
Ejemplares similares
-
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022) -
Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021) -
Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015) -
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021) -
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)